Clinical trial
Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With…
NCT00334763 · Northwestern University, Other · Terminated
Key facts
| NCT number | NCT00334763 |
|---|---|
| Title | Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung Cancer |
| Official title | Phase II Study of Radiation Followed by Paclitaxel, Carboplatin, and Bevacizumab (PCA) in Patients With Stage IIIB and IV Squamous Non-Small Cell Lung Cancer |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Biological, Drug, Radiation |
| Interventions | bevacizumab, carboplatin, chemoprotection, paclitaxel, radiation therapy |
| Enrollment | 32 |
| Start date | May 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Jun 8, 2006 |
| Last update posted | Jul 10, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: